The effects of selective destruction of the catecholamine innervation of the nucleus tractus solitarii (NTS) on arterial pressure (MAP) and heart rate (HR) were examined in unanesthetized rats in which 6-hydroxydopamine (6-OHDA), 1 ;J, was injected bilaterally into the nucleus at the level of the obex. Control rats received 1 fil of vehicle or were uninjected. Baroreceptor reflex activity was tested by measuring the reflex bradycardia in response to graded doses of phenylephrine. 6-OHDA, 2 /ig, did not alter MAP or HR; 12 /ig, a dose producing necrosis of NTS, resulted in the development within 4-6 hours of fulminating arterial hypertension and tachycardia. 6-OHDA, 4 fig, produced an elevation of MAP which returned to control levels by 48 hours without changing HR. By 6 hours, however, the arterial pressure became extremely labile. Lability of MAP in the absence of hypertension or change of HR persisted for the longest period of observation, 2 weeks. Baroreceptor reflex activity remained, although the sensitivity of the reflex was depressed. 6-OHDA, 4 /ig, failed to produce histological damage to NTS. Biochemically, it resulted after 14 days in a reduction of the activity of dopamine /3-hydroxylase, a specific marker of noradrenergic and adrenergic neurons, to 40% of control without altering the activity of choline acetyltransferase, a marker of cholinergic neurons. We conclude that selective removal of a substantial portion of the catecholamine innervation of the NTS, mostly noradrenergic, results in persistent lability without elevation of arterial pressure. The results suggest that the catecholamine innervation of NTS modulates rather than mediates baroreceptor reflexes, serving to maintain arterial pressure within narrow limits.
THE NUCLEUS tractus solitarii (NTS), a nucleus of the medulla oblongata, plays an essential role in the central neural integration of cardiovascular activity. The intermediate region of the nucleus, located at the level of the obex, serves as the primary relay area for arterial baro-and chemoreceptor reflexes. 1 " 3 Bilateral lesions of this area result not only in the abolition of arterial baroreceptor reflexes, 4 " 6 but also in the development of neurogenic arterial hypertension, fulminating in rats 4 ' 5 ' 7 and chronic and labile in cats. 6 The NTS and adjacent regions of the dorsal medulla are richly innervated by catecholaminecontaining neurons. 8 " 11 It has been presumed on the basis of histofluorescence that most of the catecholamine-containing fibers innervating NTS are noradrenergic. However, recent immunocytochemical 12 and biochemical 13 evidence has suggested that some of the catecholamines in NTS also may be adrenaline. Since central catecholamine-containing neurons play a role in blood pressure regulation, 14 ' 15 it has been proposed that some of their effects may be exerted at the level of the NTS. 5 ' 7 The principal evidence to support the contention is that norepinephrine or a-methylnorepinephrine directly injected into NTS will produce hypotension which can be blocked by phentolamine. 7 However, the long-term effects of interruption of the noradrenergic innervation of NTS remain unknown.
In this study we have investigated the effects on the arterial pressure of selective destruction of the catecholaminergic innervation of NTS by microinjection of 6-hydroxydopamine (6-OHDA) into the nucleus. In appropriate concentrations, 6-OHDA can produce selective chemical lesions of terminals of noradrenergic, but not adrenergic, neurons. 16 After administering the injections we continuously monitored the arterial pressure and heart rate (HR) in freely moving unanesthetized rats for up to 2 weeks. We have observed that selective destruction of this innervation results in the development of persistent lability of the arterial pressure without changes in the average level of arterial pressure.
Methods

General
Experiments were performed on male Sprague-Dawley rats (300-400 g). At 1-2 days before the experiment, they were transferred to the laboratory and housed individually in shoebox cages with free access to food and water and allowed to become acclimatized to the new environment. Three groups of rats, all instrumented for measurement of cardiovascular activity, were studied: (1) an experimental group in which 6-OHDA was injected into NTS; (2) operated controls that received injections of equal volumes of vehicle; (3) a group of unoperated rats matched for age, sex, and strain.
Chronic Recording of Arterial Pressure and HR
The rats were anesthetized with 2% halothane in 100% O 2 blown over the nose through a face mask. A polyvinyl chloride (PVC) catheter (PVC 0.012 inch, i.d.) filled with saline containing heparin (20 U/ml) was inserted into the thoracic aorta via the left common carotid artery and the tip placed at the level of the diaphragm. Another catheter (PVC 0.012 inch, i.d.) was inserted into a branch of the right jugular vein and the tip positioned just above the right atrium. After the cannulas were fixed to the soft tissues with sutures, the free ends were passed subcutaneously behind the ear to the back of the neck and brought through the skin through a stab wound. The neck wounds were closed with sutures and infiltrated with 2% procaine, and the rats were returned to their cages. The cannulas were flushed twice daily with 0.2 ml of saline containing heparin (50 U/ml) and sealed with stainless steel obturators when not recording cardiovascular activity. Most of the cannulas remained patent for at least 1 week.
Because of small renal infarcts that developed over time as a consequence of embolization from the tip of the indwelling arterial cannula, no rat was studied for longer than 1 week after cannulation. However, to permit evaluation of the changes in arterial pressure over a prolonged period of time in any group of rats, the dates of instrumentation and administration of 6-OHDA were varied. In some experiments, the arterial and venous cannulas were inserted first, the rats were permitted to recover, and baseline cardiovascular activity was recorded before microinjection of 6-OHDA into the NTS. In some, both procedures were done in one operation, whereas in still others the microinjection preceded instrumentation. In this way cardiovascular activity could be monitored several days after drug treatment.
When the rats were killed, the kidneys were inspected for evidence of infarctions; if such was observed, data for that rat was not included in the study. Such damage occurred in less than 5% of all rats in the series.
To record arterial pressure and HR, the arterial cannula of the unanesthetized, freely moving rat was connected to a strain gauge transducer (Statham P23Db) placed outside the cage at the heart level. Pulsatile and mean arterial pressure (MAP) were displayed on a polygraph (Beckman Dynograph type R). HR was computed from the blood pressure pulse wave by a cardiotachometer (Beckman 9857) and was displayed simultaneously.
Analysis of the Changes in MAP and HR
The changes in MAP and HR were assessed by the generation of frequency-interval histograms, 6 ' 1V using a laboratory computer (Varian 620/L). The histograms of MAP and HR indicate the incidence with which a variable assumes a certain value during a selected time period. With this method of analysis it is possible to calculate the average (mean) value and standard deviation (SD) for each variable. The SD, a measurement of the dispersion of the responses about the average value, served as an index of lability. 6 ' 17 Cardiovasular activity was recorded for 1 hour during periods of quiet wakefulness, usually between 9 a.m. and 3 p.m. The output of the Dynograph was recorded on magnetic tape (Ampex SP300) for subsequent analysis or fed directly into the analog-to-digital converter of the computer. From a sampling rate of 40 Hz, the mean values of MAP and HR for each second of the 1-hour recording period were calculated by the computer. These data points were used to generate individual frequency histograms and to calculate the average values and standard deviations of each variable.
Determination of Baroreceptor Reflex Sensitivity
Baroreceptor reflex activity was examined in unanesthetized rats by a modification of the method of Smyth et al. 18 We measured the slope of the curve describing the magnitude of the reflex bradycardia elicited in response to elevations of arterial pressure produced by graded doses of phenylephrine (Winthrop). Phenylephrine (0.1-10 jug/kg) was prepared immediately before use and administered intravenously as a 0.1-ml bolus. The sensitivity of the reflex was defined by the slope of the HR interval/elevation in pressure curve obtained for each rat from at least four different doses.
Microinjection of 6-Hydroxydopamine (6-OHDA) into the Nucleus Tractus Solitarii (NTS)
While anesthetized with halothane, the rat was placed in a stereotaxic frame with the head flexed to 45°. The region of the obex was exposed by a VOL. 43, No. 4, OCTOBER 1978 limited occipital craniotomy, and, in some rats, retraction of the posterior vermis of the cerebellum.
Drugs were injected into the region of the NTS via a glass micropipette (tip diameter, o.d. <100 /xm) joined to a Hamilton syringe (10 jul) with polyethylene tubing (PE 50). The micropipette and tubing were filled with either 6-OHDA hydrobromide (Regis) plus vehicle (0.8% ascorbic acid in saline), or vehicle alone, and connected to the filled syringe. The 6-OHDA mixture was prepared each day by dissolving 6-OHDA in freshly made vehicle and storing on ice prior to use. A new micropipette was used for each rat.
The micropipette was attached to an electrode carrier placed on the stereotaxic frame, and with the aid of a dissection scope, inserted into the NTS. All stereotaxic placements were made with reference to the obex as the rostral-caudal and lateral zero. The drugs were microinjected into the NTS at the level of the obex, 0.8 mm lateral to and 0.6 mm beneath the ependymal surface.
One microliter (total volume) of the drug or of vehicle was injected into the NTS at a rate of 0.1 jul/min with a microinfusion pump (Sage 255). After completion of injection, the cannula was left in place for 5 minutes to minimize leakage. In almost all instances, the injections were made bilaterally.
After administration of the drug, the wound was closed, and the edges were infiltrated with 2% procaine. The anesthesia was discontinued and the rat was returned to its cage and allowed free access to food and water.
Controls for Specificity of 6-OHDA
Since high concentrations of 6-OHDA may damage the brain nonselectively, 19 ' 20 we carefully assessed with biochemical and histological techniques the possibility that injection of the drug directly into NTS had specific effects on catecholamine neurons.
Biochemical Examination of the NTS
Biochemical specificity was assessed by measuring changes in the activities of the enzymes dopamine yS-hydroxylase (DBH) and choline acetyltransferase (CAT) in the region of the NTS 14 days after injection of 6-OHDA into the NTS. This is the time at which maximal degeneration of central noradrenergic neurons occurs following injury. 21 Our criterion of selectivity was a reduction in DBH, a specific biochemical marker of noradrenergic and possibly adrenergic neurons, without any change in the activity of CAT, a specific marker of cholinergic neurons. Anatomical and biochemical studies show that the region of the NTS is rich in enzymes subserving catecholamine 8 ' 911 and acetylcholine 22 biosynthesis.
Rats treated with 6-OHDA and untreated control rats were killed by cervical dislocation and the brains were quickly removed. The cerebellum was removed and a 2-mm block of medulla was isolated by transecting the brainstem with a razor blade 1 mm rostral and 1 mm caudal to the obex. The section was placed on dry ice and the NTS isolated as illustrated in Figure 1 . The tissue was kept frozen until assayed, usually within 3 days.
The paired NTS regions of each rat were weighed and homogenized in 125 pil of 5 DIM Tris buffer (pH 7.4) containing 0.2% Triton X-100. After centrifugation at 6000 g for 10 minutes, the supernatant fluid was decanted, and samples were taken for the enzyme assay. DBH activity was assayed by a modification of the method of Molinoff et al. 23 CAT activity was assayed by modification of the method of Schrier and Shuster. 24 Histological Examination of the NTS 6-OHDA-treated, vehicle-treated, and uninjected control rats were reanesthetized and killed 2 weeks after unilateral or bilateral administration of 6-OHDA by perfusion through the heart with formalin (4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.2) for 15 minutes. In each of the three groups, three or four rats were examined. The brain was removed, fixed in 10% formalin, and embedded in paraffin. Serial sections through the NTS region, 10 ju.m thick, were stained for cells by the Nissl method and examined for evidence of cell loss and/or gliosis.
Statistical Evaluation
Group statistics were computed by averaging the means and the standard deviations from all rats belonging to the same group. The significance of changes in the cardiovascular responses resulting from the administration of 6-OHDA was determined by the two-tailed Student's £-test. 25 Student's t-test was also used to determine significant changes in enzyme activity. Baroreceptor reflex sensitivity curves were calculated by linear regression.
Results
Acute Effects of Microinjection of 6-OHDA into NTS on Arterial Pressure and HR: Dose-Response Relationship
Initially we examined the effects on cardiovascular activity of bilateral microinjections of three different doses of 6-OHDA (2, 4, and 12 jug of the base, in 1 fd of vehicle) into the area of the NTS. Cardiovascular activity was measured during the first 4-6 hours after cessation of anesthesia and, thereafter, daily for up to 5 days after cannulation.
Administration of 2 fig of 6-OHDA to five rats failed to alter blood pressure or HR when compared to vehicle-treated or unoperated controls (Fig. 2 , A and B; Table 1 ).
In. six rats, administration of 12 fig of the drug resulted in the development of acute arterial hypertension ( Fig. 2D ). Within 10 minutes after cessation of anesthesia, the MAP was elevated and continued to increase, reaching maximum levels (168 ± 4 mm Hg, P < 0.001 in comparison to control) within 30-40 minutes. The HR was increased in five of six rats (444 ± 28 beats/min, P < 0.001), but its time course was more variable. The hypertension and progressive tachycardia were sustained for 2-4 hours. The rats then rapidly developed pulmonary edema and died after a rapid fall of arterial pressure. This acute hypertensive syndrome was similar to that seen after bilateral electrolytic lesion of the NTS in rats. 4 ' 7 In contrast, 4 jug of 6-OHDA produced, in the first 24 hours, a moderate increase in blood pressure. This dose also produced a marked persistent lability of the arterial pressure, evident 2-6 hours after injection, without a concomitant change in HR ( Fig. 2C cholamine denervation of the NTS, since the rats survived treatment and showed marked changes in cardiovascular activity.
Chronic Effect of 6-OHDA (4 jug) on Lability of Arterial Pressure By 48 hours after the administration of 4 fig of 6 -OHDA, the average arterial pressure had returned to the control level, and the lability of the arterial pressure was maintained. In such rats, marked swings of the arterial pressure, sometimes as great as 100 mm Hg systolic, occurred spontaneously, i.e., unrelated to changes in overt behavior, locomotion, or the pattern of respiration. A representative example of such lability is shown in a strip chart record ( Fig. 3) , in which the arterial pressure and HR were recorded from the same rat during periods of quiet wakefulness before, and 3 days after, microinjection of 6-OHDA into NTS.
Frequency-interval histograms of blood pressure and HR before and after treatment of an individual rat and a group of five representative controls (vehicle-treated) and five representative rats treated with 6-OHDA are illustrated in Figure 4 . In the normal, freely moving rat, the average MAP was 114 ± 3 mm Hg, well within the range reported by others using comparable methods. 26 ' 27 As with the dog 17 and cat, 6 the arterial pressure of the awake unrestrained rat is maintained within relatively narrow limits as reflected by the prominent and narrow peak of the frequency-interval histogram of the MAP (Fig. 4A) . In contrast to the arterial pressure, the HR is much more labile, as reflected in the histogram exhibiting a broader distribution (Fig.  4B ). Bilateral microinjections of 6-OHDA (4 ug/wl) into NTS did not alter the average MAP (Tabfe 2). However, it produced a marked increase in the SD of pressure, as reflected by the wide distribution of the frequency histogram curves ( Fig. 4A and E) when compared with vehicle-injected rats (Fig. 4C ) in which the distribution of arterial pressure did not differ from uninjected controls (Fig. 4A ). The increase in the SD of the MAP (Table 2) indicates quantitatively an increase in lability of MAP. Treatment with vehicle or 6-OHDA did not elicit changes in HR, yet the distribution of HR in the 6-0HDAtreated rats was significantly reduced ( Fig. 4D and F; Table 2 ). However, the difference in lability of HR was not maintained (see below).
The lability of the arterial pressure was extremely sensitive to anesthesia: it disappeared if the rats were briefly reanesthetized with 2% halothane and reappeared within 30 minutes after cessation of anesthesia. This demonstrates the necessity of ex- 
FIGURE 4 Frequency histograms of mean arterial pressure (left) and heart rate (right) recorded from control (vehicle-injected) rats and rats treated with 6-OHDA (4 fig in 1 ixl) during periods of quiet wakefulness. A and B: Records from a single rat before and 2 days after microinjection of 6-OHDA bilaterally into NTS. C and D: Overlay of histograms from five controls 4 days after the bilateral microinjection of 1 pi of vehicle into NTS. E and F: Overlay of histograms of five rats 4 days after microinjection of 6-OHDA.
amining the effects of 6-OHDA treatment in unanesthetized animals.
Time Course of the Cardiovascular Effects of 6-OHDA
The time course of the changes in the average and SD of the MAP and HR induced by 4 jug of 6-OHDA are illustrated in Figure 5 , A and B. After a transient elevation of arterial pressure during the first 24 hours, the MAP of treated rats returned to and remained at control levels. In contrast, increased lability of the arterial pressure was evident within the first 24 hours; it persisted for up to 11 days. Two rats were monitored 16 days after 6-OHDA treatment, the longest period of observation to date, and the lability was maintained. The aver- All statistics were computed from the frequency histograms of the group data shown in age HR of the treated rats did not differ from that of the controls (Fig. 5B) ; however, there was a tendency, not usually significant, for a reduction of its lability.
Changes in Baroreceptor Reflexes after 6-OHDA
The cardiovagal component of the baroreceptor reflex was elicited by abrupt elevations of the arterial pressure following administration of phenylephrine (0.1-10 ^g/kg, iv) 18 in five rats 3 days after injections of 4 j^g of 6-OHDA into NTS. In these rats, neither the magnitude nor duration of the dose-dependent elevation of MAP elicited by phenylephrine differed from those of unoperated controls or vehicle-injected controls (Fig. 6 ). In 6-OHDA rats the baroreceptor reflex was present. However, the gain of the response, in comparison with that of vehicle-treated controls, was significantly reduced ( Figs. 6 and 7) .
Histological and Biochemical Changes of the NTS Region Produced by 6-OHDA
Histology
There was no evidence of loss of neurons nor was there gliosis in the region of the NTS 1-2 weeks after the microinjection of the effective dose of 6-OHDA (4 /ig//xl).
In contrast, a high dose of 6-OHDA (12 jug/jitl) injected unilaterally into the NTS destroyed most of the lateral portions of NTS and adjacent tractus solitarius. As illustrated in a representative example (Fig. 8) , the chemical lesions were ovoid with a central area of necrosis approximately 0.75 mm in diameter. The necrotic area extended from the dorsal surface of the brainstem to the tractus solitarius, lateral NTS, and parts of the dorsal motor nucleus of the vagus and medial NTS, and was surrounded by a thin border of glial elements leaving a sharp demarcation (Fig. 8B) between the lesion and the surrounding normal parenchyma. The nonspecific lesion produced by a unilateral injection of 6-OHDA (12 /ig//il) is comparable in its size to that produced by electrolytic lesions of the area 4 and would, therefore, account for the acute fulminating hypertension produced by bilateral microinjection of this high dose of 6-OHDA.
Biochemical Studies
Fourteen days after treatment with 4 ng of 6-OHDA, DBH activity in the NTS was reduced to computed from frequency histograms recorded daily over a 1-hour period during the day (see Methods for details). Note that the MAP is elevated only during the first 24 hours while the lability persists. The mean HR is unchanged by 6-OHDA, yet there is a tendency on several days for the HR to stabilize as reflected by a decrease in lability. Controls, n = 15. Numbers of rats examined on a particular day after treatment are indicated in parentheses in upper panel. *P < 0.05; **P< 0.01. 40% of control (P < 0.001), whereas the activity of CAT was not significantly altered (Table 3) . However, in three rats that survived bilateral microinjections of 6 jug of 6-OHDA, the activities of both DBH and CAT were significantly reduced (Table  3) , demonstrating nonspecific effects on choiinergic neurons as well as effects on catecholaminergic neurons. In contrast, the effects of the 4-jug dose were more selective; it destroyed a major portion of the catecholaminergic innervation of NTS while sparing the choiinergic system, as well as some of the catecholamine-containing cell bodies. These are more resistant to 6-OHDA, 1928 lie within the NTS and adjacent dorsal motor nucleus of the vagus, and probably account for the remaining DBH activity.
Discussion
This study demonstrates that, in rats, the bilateral microinjection of 4 jug of 6-OHDA into the NTS results in the development of a persistent lability of the arterial pressure without hypertension or changes in HR. Despite such treatment, the cardiovagal component of the baroreceptor reflex is present. The lability of the arterial pressure produced by 6-OHDA can be detected only by intravascular recording techniques and is exquisitely sensitive to anesthesia. These two facts emphasize the necessity of measuring blood pressure in animals instrumented for the chronic recording of blood pressure while alert and freely moving.
The cardiovascular responses to focal administration of 6-OHDA are dose-dependent and not attributable to mechanical damage of the nucleus by the injection. Administration of 2 jug of the drug does not alter cardiovascular activity; 4 jug produces la-bility of arterial pressure, and 12 jug elicits fulminating hypertension. The fulminating hypertension produced by 12 jug is similar to that resulting from electrolytic lesions of the nucleus 4 and is in agreement with observations by others that, in higher doses, 6-OHDA produces nonspecific damage. 19 ' 20 The lability of the arterial pressure produced by 4 jug of 6-OHDA can, for several reasons, be attributed to a selective removal of substantial portions of the catecholaminergic innervation of the nucleus. First, morphologically, treatment with 4 jug did not produce any evidence, by light microscopy, of neuronal loss or gliosis in NTS. This finding indicates that the damage was principally restricted to small fibers penetrating the region. Second, biochemically, the reduction of DBH activity to 40% of control without significant changes of the activity of CAT indicates that the destruction of the catecholamine-containing fibers (either noradrenergic or adrenergic) was selective and not associated with any substantial damage to cholinergic fibers in the region. Third, the physiological evidence of preservation of baroreceptor reflexes and the absence of hypertension after treatment with 4 jug of 6-OHDA indicates that the drug did not substantially damage primary baroreceptor afferents or their cells of termination. Destruction of sinoaortic afferents in rats by peripheral transection, 26 by central transection of entering rootlets, 29 or by electrolytic lesions of the nucleus 4 ' 5 invariably results in abolition of baroreceptor reflexes and hypertension. Although the reduction in the gain of the baroreceptor reflexes produced by the drug might suggest some partial Uninjected rats served as controls. Results are expressed as mean ± SE. n = number of rats; numbers in parentheses denote percent of control. ' P< 0.001. t Not significant. VOL. 43, No. 4, OCTOBER 1978 damage to the afferents, this possibility seems unlikely because partial denervation of the baroreceptors results in hypertension. 26 ' 30 It is evident from the persistence of 40% of DBH in the NTS after treatment with 4 jug of 6-OHDA that this dose does not completely destroy all catecholamine-containing elements in the area. The localization of the remaining enzyme is unknown. Several possibilities should be considered. First, it may be contained in catecholamine-containing terminals which lie outside of the area affected by the drug but included in the region removed for biochemical assay. Second, the enzyme may be present in catecholamine-containing fibers which survive treatment. Third, the enzyme might be contained in the relatively few cell bodies of noradrenergic neurons which reside in the area of the NTS in rat. 8 " 11 The noradrenergic cell bodies are reputedly more resistant to the toxic action of the drug than are the terminals. 19 ' 28 Finally, the enzyme might be contained in the few adrenaline-producing (i.e., adrenergic) neurons in the region of NTS which reputedly also are more resistant to the drug. 16 If indeed the physiological functions of the remaining catecholamine-containing fibers within NTS are comparable to functions of those which are destroyed, it is conceivable that complete destruction of all catecholamine-containing fibers in the region could result in a more intense syndrome of lability and possibly even hypertension.
The present study, while demonstrating that partial destruction of the catecholamine innervation in NTS results in changes in cardiovascular activity, does not answer the question as to whether the affected neurons were noradrenergic, dopaminergic, or adrenergic, or a combination of these. It is generally believed that the major extrinsic catecholamine innervation of NTS is derived from fibers arising from the so-called A2 neuronal group lying mainly in the region of the commissural nucleus. 9 ' n Since these cells can be shown by histofluorescence to contain catecholamines, 8 and by immunocytochemistry to contain DBH 9 but not phenylethanolamine iV-methyltransferase, 12 it must be assumed, therefore, that the major innervation of NTS by A2 is noradrenergic. In support of this conclusion is the biochemical evidence that the content of noradrenaline in NTS is far greater than that of either dopamine or adrenaline. 31 ' 32 Therefore, it is probable that the lability of pressure produced by 6-OHDA results mainly from damage of the noradrenergic innervation of the nucleus. This conclusion is consistent with our observations that electrolytic lesions of A2 will result in changes in arterial pressure indistinguishable from those produced by 6-OHDA (unpublished observation). However, damage to catecholaminergic fibers other than those containing noradrenaline within NTS cannot be excluded and thus may contribute to the syndrome.
The assumption that local administration of 4 /tg of 6-OHDA in NTS preponderantly damages the noradrenergic innervation leads to two conclusions: first, the primary baroreceptor afferents in NTS are not catecholaminergic. This conclusion is supported by histochemical findings that the catecholaminergic innervation of NTS is not affected by the deafferation of baroreceptors 10 and that catecholamine-containing fibers are not present in the carotid sinus region of the rat. 33 Second, the syndrome of fulminating hypertension produced by electrolytic lesions of NTS is not a consequence of damage sustained by the intrinsic catecholamine-containing fibers but rather must result from more extensive damage to entering baroreceptor fibers and/or the cells of their termination. 4 " 6 ' 29 Thus it appears that the catecholamine innervation of that portion of the NTS lying at the obex plays an important role in modulating rather than mediating baroreceptor reflex activity. This modulation appears to stabilize the arterial pressure by acting in concert with the baroreceptor reflex mechanisms. Moreover, it is conceivable that the catecholamine modulation may facilitate the vagal excitatory and even possibly the vasodepressor components of the baroreceptor reflex arc. This contention is supported by the findings of others obtained in anesthetized animals that reflex bradycardia produced by elevation of arterial pressure is facilitated by the intracisternal administration of clonidine, an a-adrenergic agonist, 34 ' 35 that norepinephrine injected directly into NTS acutely and transiently lowers blood pressure and HR (an effect, blocked by a-adrenergic antagonists), 7 and that the depressor effects of a-methylnorepinephrine is mediated, in part, through a-adrenergic receptors within the NTS itself. 36 Although we failed to obtain chronic changes in HR following microinjection of 6-OHDA into the NTS, others have noted that the injection of norepinephrine directly into NTS produces bradycardia. 7 Since we have not directly injected norepinephrine into the NTS, we can only speculate as to the reasons for the discrepancy between our results and those of others. First of all, the responses described by others were obtained from acute studies on anesthetized animals. Thus, the transient alterations could be dependent on the concentration of norepinephrine which bathes the NTS when administered as a bolus, or they could be related to the anesthesia. Another possibility is that the tonic effects of the catecholamine innervation of NTS on resting HR may be minimal and, therefore, the removal of this innervation might not alter HR responses. That this may indeed be a possibility is suggested by the observation that when phentolamine is administered directly into the NTS, it fails to alter HR, but abolishes the effects of the local application of norepinephrine in slowing the HR. 7 
